[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019-2023 U.S. Microbiology Automated Market: Supplier Shares and Strategies, Country Segment Forecasts, Technology and Instrumentation Review--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

February 2019 | 436 pages | ID: 2F170F51EF1EN
Venture Planning Group

US$ 9,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400.

LeadingMarketResearch.com's new report is an analysis of major business opportunities emerging in the U.S. automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding market, in evaluating emerging opportunities and developing effective business strategies.

Market Segmentation Analysis
  • Sales and market shares for major suppliers by individual test.
  • Volume and sales forecasts for over 100 infectious disease assays by individual test:
  • Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
  • Review of the market dynamics, trends, structure, size, growth and major suppliers.
Specimen Types
  • Urine
  • Sterile Fluids: Blood, Serum, CSF
  • Throat Swabs, Respiratory Secretions
  • Genital Secretions
  • Stool
  • Abscess/Wound
  • Sputum
  • Saliva
Applications
  • Microbial Identification
  • Antibiotic Susceptibility
  • Urine Screening
  • Blood Cultures
Review of Major Automated Systems
  • Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
  • The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.
Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review
  • Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
  • Global listings of companies developing or marketing microbiology products by individual test.
Competitive Assessments
  • Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
  • The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux, Bio-Rad, Biotest, CellMark Forensics/LabCorp, Cepheid, Decode Genetics, Diadexus, Diamedix/Erba, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, ID Biomedical/GSK, Illumina, Kreatech/Leica, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Shimadzu, Siemens, Sierra Molecular, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.
Opportunities and Strategic Recommendations
  • Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
  • Design criteria for decentralized testing products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Contains 436 pages and 94 tables
I. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Introduction
  1. MAJOR FACTORS AFFECTING MARKET PENETRATION OF MICROBIOLOGY INSTRUMENTATION
  2. TRADITIONAL PRACTICES
  3. TECHNOLOGICAL CHALLENGES
  4. AUTOMATION: IMPACT ON THE MICROBIOLOGY LABORATORY AND THE PATIENT
B. Major Specimen Types
  1. URINE
  2. STERILE FLUIDS: BLOOD, SERUM, AND CSF
  3. THROAT SWABS AND RESPIRATORY SECRETIONS
  4. GENITAL SECRETIONS
  5. STOOL
  6. ABSCESS/WOUND
  7. SPUTUM
  8. SALIVA
C. Test Applications
  1. MICROBIAL IDENTIFICATION
  2. ANTIBIOTIC SUSCEPTIBILITY
  3. URINE SCREENING
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. BLOOD CULTURES
D. Major Microbiology Automated and Semiautomated Systems
  1. MULTIPLE PURPOSE MICROBIOLOGY SYSTEMS
  2. SPECIALIZED MICROBIOLOGY SYSTEMS
  3. MOLECULAR DIAGNOSTIC SYSTEMS
  4. IMMUNODIAGNOSTIC SYSTEMS
E. Emerging Diagnostic Technologies
  1. MOLECULAR DIAGNOSTICS
    a. DNA Sequencing
      Introduction
      Sequencing Methods
      Autoradiography
      The Human Genome Project
      Sequencing Automation
      Image Scanners
      Fluorescent Detection
      Gene Profiling
      Gene Expression
      Polymorphism Screening
      Protein Interaction Networks
    b. DNA And RNA Probe Technology
      Basic Principles
      Probe Preparation
      The DNA Probe Test
      Sample Preparation
      Hybridization
      Separation
      Detection/Measurement
      Test Formats
      Filter Hybridization
      Southern Blot
      Northern Blot
      In Situ Hybridization
      Others
      Labeling Techniques
      Amplification Methods
    Polymerase Chain Reaction
      Temperature Cyclers
      PCR Variations
      Immuno-PCR
      QC-PCR
      DAP-PCR
    Strand Displacement Activation
    TMA
    Ligase Chain Reaction
    Branched DNA
      Hybridization Protection Assay
    Nucleic-Acid Sequence-Based Amplification
    Self-Sustained Sequence Replicase
    Others
      Ampliprobe
      CAR
      CAS
      CPT
    Dendritic Polymer Technology
      ISO-CR
      LAT
    Probe
      RAMP
    Repair Chain Reaction
    Rolling Circles
    Sequence Independent Gene Amplification
    Sequence Initiation Reaction
      SISPA
    Solid Phase Amplification
  c. Detection Technologies
    Radioactive Methods
    Overview
    Major Isotopes
    P-32
    S-35
    H-3
    I-125
    Non-Isotopic Methods
    Enzymatic Labels
    Chemical Labeling
    Indirect Chemical Labeling
    Direct Chemical Labeling
    Fluorescence
    Chemiluminescence
    Electrical Conductivity
  d. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    Liquid Transportation and Mixing
    Separation
    Reaction
    Detection
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER

II.U.S.A.

A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares

III.MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

IV.DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

5. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/Lab Corp
Decode Genetics
Diadexus
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
ID Biomedical/GSK
Kreatech/Leica
Li-Cor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Sierra Molecular
Shimadzu
Takara Bio
Tecan
Thermo Fisher
Wallac/PE
Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Laboratories Performing Microbiology Tests by Market Segment
U.S.A. Hospital Laboratories Performing Microbiology Tests by Bed Size
U.S.A. Commercial/Private Laboratories Performing Microbiology Tests by Annual Test Volume
U.S.A. All Market Segments Microbiology Specimen Volume
U.S.A. Hospital Laboratories Microbiology Specimen Volume
U.S.A. Physician Offices/Group Practices Microbiology Specimen Volume
U.S.A. Public Health Laboratories Microbiology Specimen Volume
U.S.A. Commercial/Private Laboratories Microbiology Specimen Volume
U.S.A. Microbiology Test Volume by Market Segment
U.S.A. Microbiology Test Volume by Application
U.S.A. Microbial Identification Test Volume by Market Segment
U.S.A. Urine Screening Test Volume by Market Segment
U.S.A. Blood Culture Test Volume by Market Segment
U.S.A. Antibiotic Susceptibility Test Volume by Market Segment
U.S.A. Microbiology Consumables Market by Application
U.S.A. Microbiology Consumables Market by Market Segment
U.S.A. Microbial Identification Consumables Sales by Market Segment
U.S.A. Antibiotic Susceptibility Consumables Sales by Market Segment
U.S.A. Blood Culture Consumables Sales by Market Segment
U.S.A. Urine Screening Consumables Sales by Market Segment
U.S.A. All Market Segments Infectious Disease Test Volume Forecast by Assay
U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast by Test
U.S.A. Infectious Disease Blood Screening NAT Volume Forecast by Assay
U.S.A. Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
U.S.A. HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A. HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Molecular Diagnostics Market Sales and Shares of Major Suppliers


More Publications